FdaApplication
ANDA 218850
Identifiers
- fda_app_no: ANDA218850
Properties
| Property | Value |
|---|---|
| applicant_name | SPECGX LLC |
| application_type | ANDA |
| approval_date | 2024-12-17 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | 50MG | TABLET, CHEWABLE;ORAL |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | 20MG | TABLET, CHEWABLE;ORAL |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | 30MG | TABLET, CHEWABLE;ORAL |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | 40MG | TABLET, CHEWABLE;ORAL |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | 10MG | TABLET, CHEWABLE;ORAL |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | 60MG | TABLET, CHEWABLE;ORAL |
6 products